Esophageal perforation during or after conformal radiotherapy for esophageal carcinoma.

Abstract

The aim of this study was to analyze the risk factors and prognosis for patients with esophageal perforation occurring during or after radiotherapy for esophageal carcinoma. We retrospectively analyzed 322 patients with esophageal carcinoma. These patients received radiotherapy for unresectable esophageal tumors, residual tumors after operation, or local recurrence. Of these, 12 had radiotherapy to the esophagus before being admitted, 68 patients had concurrent chemoradiotherapy (CRT), and 18 patients had esophageal perforation after RT (5.8%). Covered self-expandable metallic stents were placed in 11 patients. Two patients continued RT after stenting and control of infection; one of these suffered a new perforation, and the other had a massive hemorrhage. The median overall survival was 2 months (0-3 months) compared with 17 months in the non-perforation group. In univariate analysis, the Karnofsky performance status (KPS) being ≤ 70, age younger than 60, T4 stage, a second course of radiotherapy to the esophagus, extracapsular lymph nodes (LN) involving the esophagus, a total dose >100 Gy (biologically effective dose-10), and CRT were risk factors for perforation. In multivariate analysis, age younger than 60, extracapsular LN involving the esophagus, T4 stage, and a second course of radiotherapy to the esophagus were risk factors. In conclusion, patients with T4 stage, extracapsular LN involving the esophagus, and those receiving a second course of RT should be given particular care to avoid perforation. The prognosis after perforation was poor.

• Authors: Hai-yan Chen, Xiu-mei Ma, Ming Ye, Yan-li Hou, Hua-ying Xie, Yong-rui Bai
• Journal: Journal of radiation research (J Radiat Res) Vol. 55 Issue 5 Pg. 940-7 (Sep 2014) ISSN: 1349-9157 [Electronic] England
• PMID: 24914102 (Publication Type: Journal Article)
• Copyright: © The Author 2014. Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Radiation Oncology.

Topics

• Adult
• Age Distribution
• Aged
• Aged, 80 and over
• China (epidemiology)
• Disease-Free Survival
• Esophageal Neoplasms (diagnosis, mortality, radiotherapy)
• Esophageal Perforation (etiology, mortality)
• Female
• Humans
• Male
• Middle Aged
• Prevalence
• Radiation Injuries (etiology, mortality)
• Radiotherapy Dosage
• Radiotherapy, Conformal (mortality)
• Retrospective Studies
• Risk Factors
• Survival Rate
• Treatment Outcome